Annual Net Margin
-41.52%
+149.08 K%+99.97%
31 December 2023
Summary:
CRISPR Therapeutics AG annual net profit margin is currently -41.52%, with the most recent change of +149.08 thousand% (+99.97%) on 31 December 2023. During the last 3 years, it has risen by +64.21 thousand% (+99.94%). CRSP annual net margin is now -200.39% below its all-time high of 41.36%, reached on 31 December 2021.CRSP Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Margin
N/A
30 September 2024
Summary:
CRISPR Therapeutics AG quarterly net profit margin is not available.CRSP Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRSP Net Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | - |
| 3 y3 years | +99.9% | - |
| 5 y5 years | +99.2% | - |
CRSP Net Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -200.4% | +100.0% | ||
| 5 y | 5 years | -200.4% | +100.0% | ||
| alltime | all time | -200.4% | +100.0% |
CRISPR Therapeutics AG Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -41.52%(-100.0%) | 44.67%(-140.2%) |
| June 2023 | - | -111.06%(+109.3%) |
| Mar 2023 | - | -53.07%(-100.0%) |
| Dec 2022 | -149.12 K%(<-9900.0%) | -1.84 M%(+892.5%) |
| Sept 2022 | - | -185.69 K%(+57.9%) |
| June 2022 | - | -117.62 K%(+16.8%) |
| Mar 2022 | - | -100.68 K%(+8701.9%) |
| Dec 2021 | 41.36%(-100.1%) | -1143.89%(-97.0%) |
| Sept 2021 | - | -38.65 K%(<-9900.0%) |
| June 2021 | - | 84.34%(-100.2%) |
| Mar 2021 | - | -56.02 K%(+1.5%) |
| Dec 2020 | -64.25 K%(<-9900.0%) | -55.17 K%(-11.7%) |
| Sept 2020 | - | -62.46 K%(-65.5%) |
| June 2020 | - | -181.04 K%(+307.6%) |
| Mar 2020 | - | -44.41 K%(<-9900.0%) |
| Dec 2019 | 23.09% | 39.66%(-39.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | 65.32%(-100.4%) |
| June 2019 | - | -16.89 K%(+14.4%) |
| Mar 2019 | - | -14.76 K%(-64.3%) |
| Dec 2018 | -5281.08%(+3067.3%) | -41.38 K%(+359.4%) |
| Sept 2018 | - | -9007.28%(+155.3%) |
| June 2018 | - | -3527.57%(+69.3%) |
| Mar 2018 | - | -2083.95%(<-9900.0%) |
| Dec 2017 | -166.74%(-62.9%) | 0.44%(-100.0%) |
| Sept 2017 | - | -1035.06%(+66.1%) |
| June 2017 | - | -622.98%(-21.6%) |
| Mar 2017 | - | -794.49%(-16.2%) |
| Dec 2016 | -449.30%(-95.7%) | - |
| Sept 2016 | - | -948.61%(-56.1%) |
| June 2016 | - | -2158.99%(+21.7%) |
| Mar 2016 | - | -1773.53%(-64.3%) |
| Dec 2015 | -10.46 K% | -4974.09% |
FAQ
- What is CRISPR Therapeutics AG annual net profit margin?
- What is the all time high annual net margin for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual net margin year-on-year change?
- What is the all time high quarterly net margin for CRISPR Therapeutics AG?
What is CRISPR Therapeutics AG annual net profit margin?
The current annual net margin of CRSP is -41.52%
What is the all time high annual net margin for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual net profit margin is 41.36%
What is CRISPR Therapeutics AG annual net margin year-on-year change?
Over the past year, CRSP annual net profit margin has changed by +149.08 K% (+99.97%)
What is the all time high quarterly net margin for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly net profit margin is 84.34%